Mesalaminedosage

Important Administration Instructions: Do not substitute one mesalamine delayed-release tablets 800 mg tablet for two mesalamine delayed-release 400 mg oral products. Evaluate renal function prior to initiation of mesalamine delayed-release tablets. Take on an empty stomach, at least 1 hour before and 2 hours after a meal. Swallow whole; do not cut, break or chew the tablets. Drink an adequate amount of fluids. Treatment of Moderately Active Ulcerative Colitis: Recommended dosage is 1,600 mg (two 800 mg tablets) three times daily for 6 weeks.

2.1 Important

Administration Instructions Do not substitute one mesalamine delayed-release 800 mg tablet for two mesalamine delayed-release 400 mg oral products. Evaluate renal function prior to initiation of mesalamine delayed-release tablets. Take mesalamine delayed-release tablets on an empty stomach, at least 1 hour before and 2 hours after a meal. Swallow mesalamine delayed-release tablets whole. Do not cut, break or chew the tablets. Drink an adequate amount of fluids. Intact, partially intact, and/or tablet shells have been reported in the stool; Instruct patients to contact their healthcare provider if this occurs repeatedly. Protect mesalamine delayed-release tablets from moisture.

2.2 Dosage Information

For the treatment of moderately active ulcerative colitis, the recommended dosage of mesalamine delayed-release tablets in adults is 1,600 mg (two 800 mg tablets) three times daily (total daily dosage of 4.8 grams) for a duration of 6 weeks.